Literature DB >> 12707710

[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].

Dirk Rades1, Fabian Fehlauer, Steven Schild, Karin Lamszus, Winfried Alberti.   

Abstract

BACKGROUND: Central neurocytomas are described as uncommon benign CNS lesions. Uncertainty exists about the most appropriate treatment regimen. This retrospective analysis compares four therapies for local control and overall survival: complete resection alone (KR), complete resection plus radiotherapy (KR-RT), incomplete resection alone (IR), and incomplete resection plus radiotherapy (ITR-RT).
MATERIAL AND METHODS: The cases published in the literature since 1982 were reviewed for age, gender, extent of resection, atypical neurocytoma, radiotherapy, local control, and overall survival (minimum follow-up 12 months). From direct contact with the authors additional data were obtained providing more detailed information about the patients and a longer follow-up. Statistical analysis was performed with the Kaplan-Meier analysis and the log-rank test.
RESULTS: Complete data were obtained from 358 patients (KR 118, KR-RT 35, IR 91, IR-RT 114). Local control was significantly better after KR, KR-RT and IR-RT than after IR (Figure 1). No significant difference was found between KR, KR-RT and IR-RT. Median time to progression was 36 (KR), 39 (KR-RT), 21 (IR) and 32 (IR-RT) months. The comparison of the four groups for overall survival demonstrated that KR provided a significantly better overall survival than IR (Figure 2). Overall survival rates were 99.2% and 86.1%, respectively.
CONCLUSIONS: Complete resection is much more effective for the treatment of central neurocytoma than incomplete resection. After complete resection the additional benefit of postoperative radiotherapy remains unclear. After incomplete resection postoperative radiotherapy significantly improved local control, but not overall survival.

Entities:  

Mesh:

Year:  2003        PMID: 12707710     DOI: 10.1007/s00066-003-1061-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  5 in total

1.  Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery.

Authors:  Hoan Tran; Rafael Medina-Flores; Lisa A Cerilli; Jeremy Phelps; Fa-Chyi Lee; Gene Wong; Paul Turner
Journal:  J Neurooncol       Date:  2010-03-30       Impact factor: 4.130

Review 2.  Gamma knife radiosurgery of recurrent atypical neurocytoma. Case report and review of the literature.

Authors:  R Wolff; V Seifert; A Mack; J Steinbach; C Rödel; R Heyd
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

3.  Intraventricular neurocytoma with massive brain stem involvement in a 5-year-old child.

Authors:  Jacopo Lenzi; Maurizio Salvati; Alessandro Frati; Antonino Raco; Angelo Pichierri; Felice Giangaspero; Roberto Delfini
Journal:  Childs Nerv Syst       Date:  2005-03-31       Impact factor: 1.475

4.  Central neurocytoma: a novel appraisal of a polymorphic pathology. Our experience and a review of the literature.

Authors:  Jacopo Lenzi; Maurizio Salvati; Antonino Raco; Alessandro Frati; Manolo Piccirilli; Roberto Delfini
Journal:  Neurosurg Rev       Date:  2006-04-08       Impact factor: 3.042

5.  MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.

Authors:  Gurvinder Kaur; Ari J Kane; Michael E Sughrue; Michael Oh; Michael Safaee; Matthew Sun; Terik Tihan; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2012-11-05       Impact factor: 1.961

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.